Raptor Pharmaceutical Corp Retained Earnings
Raptor Pharmaceutical Corp had Retained Earnings of -$378.72 million as of 2016-06-30, per its 10-Q filed 2016-08-04.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2016-08-04
- 2016-06-30: Retained Earnings (Accumulated Deficit) -$378.72M.
- 2016-03-31: Retained Earnings (Accumulated Deficit) -$364.70M.
- 2015-12-31: Retained Earnings (Accumulated Deficit) -$323.12M.
- 2015-09-30: Retained Earnings (Accumulated Deficit) -$306.11M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2016-06-30 | -$378.72M 10-Q · filed 2016-08-04 |
| 2016-03-31 | -$364.70M 10-Q · filed 2016-05-05 |
| 2015-12-31 | -$323.12M 10-Q · filed 2016-08-04 |
| 2015-09-30 | -$306.11M 10-Q · filed 2015-11-05 |
| 2015-06-30 | -$291.53M 10-Q · filed 2015-08-06 |
| 2015-03-31 | -$277.58M 10-Q · filed 2015-05-07 |
| 2014-12-31 | -$257.89M 10-K · filed 2016-02-26 |
| 2014-09-30 | -$238.97M 10-Q · filed 2014-11-06 |
| 2014-06-30 | -$232.94M 10-Q · filed 2014-08-07 |
| 2013-12-31 | -$205.35M 10-K · filed 2015-03-02 |
| 2012-08-31 | $116.60M 10-K · filed 2012-11-14 |